Anatara Lifesciences Share Price and Company Fundamentals



Price
$0.175
Change
0.000 (0.000%)
52 week
0.13 - 0.28

Last traded: Last Monday at 5:43 AM

Anatara Lifesciences Limited engages in the research and development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans in Australia. Its lead product candidate includes Detach, a non-antibiotic therapy that prevents and treats diarrhea disease in piglets. The company is also developing bromelain formulations for gastrointestinal health in humans, as well as for piglets and poultry. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.

Key Metrics

PE ratio

-

PB ratio

2.57

Dividend yield

Beta

0.95

Market cap

$12.7M

Enterprise value

$7.95M

Company profile

Primary activitiesDeveloping non-antibiotic oral solutions for gastrointestinal diseases in animals and humans.
Industry / SectorBiotechnology / Healthcare
Websitehttp://www.anataralifesciences.com
Mailing address62 Lygon Street Level 3 Carlton VIC 3053 Australia
Phone / Fax61 7 3394 8202 /
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Annual reports

Published onReport
27 Oct 2020Annual Report to shareholders

Dividends

Anatara Lifesciences does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Anatara Lifesciences.

NameTitleAgeTotal Pay
Mr. Steven Lydeamore CPA, M.B.A., MBA, CPAChief Exec. Officer451.85k
Dr. Michael L. WestChief Operating Officer56296.83k
Jane LoweManaging Director of IR Department
Dr. Stephen Denaro AGIA, BCom, GradDipApp CG, CA, MAICDCompany Sec.
Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing ManagementCommercial Mang.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-1,011.49%

Return on assets

-34.50%

Return on equity

-57.28%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Anatara Lifesciences is 12.7M and its enterprise value is 7.95M. The enterprise value to revenue ratio of ANR is 29.63.

The ANR's stocks Beta value is 0.95 making it 5% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Anatara Lifesciences (ANR)

Anatara Lifesciences (ASX:ANR) Frequently Asked Questions

1. What is Anatara Lifesciences's Stock Symbol?

Anatara Lifesciences trades on ASX under the ticker symbol "ANR".

2. What is Anatara Lifesciences's stock price today?

One share of ANR stock can currently be purchased for approximately $0.175.

3. How can I contact Anatara Lifesciences?

Anatara Lifesciences's mailing address is 62 Lygon Street Level 3 Carlton VIC 3053 Australia. The company can be reached via phone at 61 7 3394 8202.

4. What is Anatara Lifesciences's official website?

The official website of Anatara Lifesciences is http://www.anataralifesciences.com.

5. Which share registry manages Anatara Lifesciences's stock?

Anatara Lifesciences's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.